MDRX - Why Healthcare Data & Technology Solutions Provider Veradigm Shares Are Trading Lower Today | Benzinga
Veradigm Inc (NASDAQ: MDRX) shares are trading lower after it provided below-consensus FY23 guidance.
For FY23, the company expects revenue (on a GAAP basis) of $608 million-$622 million (vs. $637.67 million estimate), including a favorable customer litigation settlement, contributing approximately $16 million on a GAAP basis that reflects services provided over prior years.
MDRX sees adjusted EBITDA of $122 million-$135 million for FY23, excluding around $16 million favorable customer litigation settlement and certain other legal settlements.
For FY23, the ...